Oxford Nanopore Technologies
Oxford Nanopore Technologies, founded in 2005, makes a novel generation of DNA/RNA sequencing technology that provides rich data, is fast, accessible and easy to use. Their goal is to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Oxford Nanopore’s sequencing technology is used across a spectrum of biological research including human genetics, cancer research, plant/agricultural/food science, environmental, and pathogen analysis. The technology is used in more than 70 countries to sequence SARS-CoV-2, the virus that causes COVID-19. Nanopore sequencing offers real-time analysis (for rapid insights), in fully scalable formats from pocket to population scale, that can analyse native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths
Headquartered in Oxford, UK, the company has satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and sells to nearly 100 countries.